Gene · 7417
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting ST18-mediated pathomechanism in pemphigus vulgaris through voltage-dependent anion channel inhibition. | Skin Health Dis | 2026 | 41923972 | PubTator, text mining | PubMed |
| Integrated proteomics and metabolomics analysis reveals mechanisms by which SFYC decoction regulates airway inflammation in asthma. | J Ethnopharmacol | 2026 | 41921764 | PubTator, text mining | PubMed |
| Perspectives from machine learning and multi-omics to decoding the effects of VDAC2 malignant subsets on tumor evolution. | NPJ Precis Oncol | 2026 | 41917254 | PubTator, text mining | PubMed |
| L-Selenomethionine Alleviates Cryo-Induced Ferroptosis Through the NRF2-SLC7A11-GPX4 Pathway, Improving Post-Thaw In Vitro Quality of Dairy Goat Spermatozoa. | Antioxidants (Basel) | 2026 | 41897537 | PubTator, text mining | PubMed |
| The tRNA-Derived Fragment tRF-E Promotes Ferroptosis in Hepatocellular Carcinoma to Suppress Tumor Progression. | Cancer Res | 2026 | 41886622 | PubTator, text mining | PubMed |
| Chicken caspase-3 promotes IBDV replication via the cleavage of IRF7. | Front Microbiol | 2026 | 41809602 | PubTator, text mining | PubMed |
| Exosome-Mediated Intercellular Communication in the Pathological Processes of Gouty Arthritis and Its Treatment. | Int J Mol Sci | 2026 | 41751795 | PubTator, text mining | PubMed |
| Ferroptosis and immunity: rewiring the tumor microenvironment for therapy. | RSC Adv | 2026 | 41726230 | PubTator, text mining | PubMed |
| The Acid sphingomyelinase/ceramide System in Idiopathic Inflammatory Myopathies: a Potential Treatment Target. | Inflammation | 2026 | 41721077 | PubTator, text mining | PubMed |
| Dysregulated post‑translational modifications in granulosa cells drive ovarian dysfunction and potential infertility applications (Review). | Int J Mol Med | 2026 | 41716015 | PubTator, text mining | PubMed |
| Ferroptosis in diabetic retinopathy: from pathogenic mechanisms to translational prospects. | Front Endocrinol (Lausanne) | 2026 | 41710412 | PubTator, text mining | PubMed |
| VDAC1 and VDAC2 as prognostic biomarkers and therapeutic targets in hepatocellular carcinoma. | Transl Cancer Res | 2026 | 41674969 | PubTator, text mining | PubMed |
| LRRK2 regulates ArfGAP1 membrane localization, activity and neuronal toxicity via phosphorylation within its lipid-sensing ALPS2 motif. | bioRxiv | 2026 | 41648595 | PubTator, text mining | PubMed |
| VDAC2: an emerging pivotal and multifaceted regulator in tumor biology. | Apoptosis | 2026 | 41622340 | PubTator, text mining | PubMed |
| Tumor-associated macrophages display differential protein cargo sorting in extracellular vesicles associated with poor survival in ovarian cancer. | Mol Med | 2026 | 41618130 | PubTator, text mining | PubMed |
| Trim15 stabilizes VDAC3 via ubiquitination to suppress autophagy and enhance chemosensitivity in hypopharyngeal squamous cell carcinoma. | Cell Death Discov | 2026 | 41617671 | PubTator, text mining | PubMed |
| The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells. | Sci Rep | 2026 | 41577723 | PubTator, text mining | PubMed |
| Association of programmed cell death with atrial fibrillation risk: A multi-omics Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41560081 | PubTator, text mining | PubMed |
| A small molecule VDAC ligand inhibits ERAD and induces selective cancer cell death via disruption of calcium homeostasis. | Nat Commun | 2026 | 41547848 | PubTator, text mining | PubMed |
| Targeting TRIM25 as a therapeutic strategy to enhance ferroptosis in glioblastoma cells. | J Nanobiotechnology | 2026 | 41501880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7417/papers?page=2